First, decreased AML cell levels of the transferrin receptor suggest decreased uptake of iron-containing transferrin, and decreased receptor-mediated transferrin uptake is possibly reflected by the decreased AML cell transferrin levels. The gene discussed is TF; the disease is acute myeloid leukemia.